Clinical data | |
---|---|
ATC code |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C28H35NO4 |
Molar mass | 449.582 g/mol |
3D model (JSmol) | |
|
|
|
|
(what is this?) |
Asoprisnil (INN) (developmental code name J-867) is a synthetic, steroidal selective progesterone receptor modulator (SPRM) which was under development by Schering and TAP Pharmaceutical Products for the treatment of uterine fibroids. In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.